Quarter 1 2017 Increase / (Decrease) % Change Revenues from sales 214.32 96.56 117.76 121.96% Other revenues 0.24 0.44 (0.20) (45.45%) Total revenues 214.56 97.00 117.56 121.20% Cost of sales 77.95 42.84
-patients were Baht 171.18 mllion and 178.81 million respectively, which increased by 4.5%. An increase was primarily due to the increment in average revenue per visit both in-patient and out-patient. Also
12.20 14.36% The increase in revenue came from sales increment in Wellness & Anti-Aging products by the amount of 47.77 million baht which grew by 15.90 million baht or 49.90%. The increment mainly driven
should continue to be accommodative so that the economic growth could continue and translate into the strengthening of domestic demand. Notwithstanding this, there are pockets of risks, such as debt
. Analysis of Cost and Expenses 1. In Q2 2017, Cost of sales was 3,632 MTHB, increased by 127 MTHB comparing to 2016 or 3.6% due to the increase of sales volumes and higher Glycerin costs from tight market
MTHB, increased by 885 MTHB comparing to 2016 or 29.1% due to higher sales volumes plus Ethylene and Glycerin price increase. The rise of Ethylene price was caused by turnaround of North East Asia
countries. The Company’s gross profit demonstrated at 33.8% to sale value, declined from same quarter last year reported at 37.2% due to the increase in energy prices and Thai Baht appreciation against US
diminished by the increment of distribution costs and administrative expenses, plus foreign currency differences on dissolution of its subsidiaries as mentioned above. At the bottom line, the Company and its
: Financial Assumption Income 2020 is based on actual income of 1st Quarter 2020, hence, 2020 income is approximately 250 million Baht and beginning of 2021 is set to increase by 4.6% per year according to the
– June. However, when considered the revenue from sales of goods for the 9-month period ended 30 September, 2018, there is a growth in overall performance with 18.65% when compared to the sales of 9-month